In-depth coverage and real-time reporting for the Healthcare & Pharma sector. Professional analysis for industry leaders.
BCG's 2026 biopharma outlook examines how pharmaceutical companies are reinventing business models amid AI adoption, patent expiries, evolving regulations and shifting market dynamics.
Analysis of the 2026 healthcare insurance market reveals rising claim severity, social inflation, and regulatory pressures despite increased carrier competition and new capacity across senior care, hospitals, life sciences, and allied health segments.
The 44th annual J.P. Morgan Healthcare Conference in San Francisco (February
When a cleaned fact list returns an error for political content, information
The pharmaceutical industry is undergoing a transformative shift as it approaches
A scoping review published in Daru (2024) synthesizes 24 studies from 3,617